USPTO serial 79444894
K.AI
Reviewed by CopyMark Law Group
Status 640Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- JANSON, ANDREW KYLE
- Law office
- TMEG LAW OFFICE 105
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with K.AI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Software for a manufacturing execution system (MES) in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines; software for recording, analysing, processing, presenting and managing production data, in particular production data from or for a manufacturing execution system (MES), in particular in the pharmaceutical industry or biotech industry, in particular a chatbot in the form of a digital avatar being an interactive helper, in particular using artificial intelligence; software for assistance in compliance, quality control and documentation processes in a manufacturing execution system (MES), in particular in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines; software for text analysis, voice recognition and voice response, in particular in connection with the creation, processing, adaptation, maintenance, providing, development and/or verification management of electronic batch records (EBR), a batch record review (BRR), master batch records (MBR) or a track and trace process; software for text analysis, voice recognition and voice response for the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, more specifically software for use with artificial intelligence; artificial-intelligence-based software for a manufacturing execution system (MES) in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines; artificial-intelligence-based software for recording, analysing, processing, presenting and managing production data, in particular production data from or for a manufacturing execution system (MES), in particular in the pharmaceutical industry or biotech industry, in particular a chatbot in the form of a digital avatar being an interactive helper, in particular using artificial intelligence; artificial-intelligence-based software for assistance in compliance, quality control and documentation processes in a manufacturing execution system (MES), in particular in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines; artificial-intelligence-based software for text analysis, voice recognition and voice response, in particular in connection with the creation, processing, adaptation, maintenance, providing, development and/or verification management of electronic batch records (EBR), a batch record review (BRR), master batch records (MBR) or a track and trace process; chatbots with artificial-intelligence-based software for a manufacturing execution system (MES) in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines; chatbots with artificial-intelligence-based software for recording, analysing, processing, presenting and managing production data, in particular production data from or for a manufacturing execution system (MES), in particular in the pharmaceutical industry or biotech industry, in particular a chatbot in the form of a digital avatar being an interactive helper, in particular using artificial intelligence; chatbots with artificial-intelligence-based software for assistance in compliance, quality control and documentation processes in a manufacturing execution system (MES), in particular in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines; chatbots with artificial-intelligence-based software for text analysis, voice recognition and voice response, in particular in connection with the creation, processing, adaptation, maintenance, providing, development and/or verification management of electronic batch records (EBR), a batch record review (BRR), master batch records (MBR) or a track and trace process; chatbots for assistance in production and quality control processes, in particular in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, in particular a chatbot in the form of a digital avatar being an interactive helper; chatbots for assistance in maintenance and verification processes, in particular in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, in particular in the form of a digital avatar being an interactive helper; chatbots for controlling industrial processes, in particular in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, more specifically chatbots using artificial intelligence; chatbots for analysing company and process data, in particular in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, more specifically chatbots using artificial intelligence; chatbots for data and file management and for databases, in particular in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, more specifically chatbots using artificial intelligence; chatbots for [process] data management, in particular in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, more specifically chatbots using artificial intelligence; chatbots for [process] data visualisation, in particular in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, more specifically chatbots using artificial intelligence; chatbots for automated reporting, in particular in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, more specifically chatbots using artificial intelligence; chatbots for controlling machines, in particular in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, more specifically chatbots using artificial intelligence; chatbots for managing supply chains, in particular in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, more specifically chatbots using artificial intelligence; chatbots for factory automation, in particular in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, more specifically chatbots using artificial intelligence; downloadable mobile applications, in particular for the transmission of information in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, more specifically chatbots using artificial intelligence; chatbots for mobile devices, in particular in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, more specifically chatbots using artificial intelligence; chatbots for robot process automation [RPA] in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, more specifically chatbots using artificial intelligence; chatbots for industrial automation, in particular in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, more specifically chatbots using artificial intelligence; chatbots for production management systems, in particular in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, more specifically chatbots using artificial intelligence; chatbots for cell and gene therapy production, in particular chatbots using artificial intelligence; chatbots for quality control and assurance, in particular in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, more specifically chatbots using artificial intelligence; chatbots for documenting and reporting production processes, in particular in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, more specifically chatbots using artificial intelligence; chatbots for product lifecycle management, in particular in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, more specifically chatbots using artificial intelligence; chatbots for the development of medicines and agents in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, more specifically chatbots using artificial intelligence; chatbots for process development in medicine manufacturing in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, more specifically chatbots using artificial intelligence; software; computer software packages; artificial intelligence software; artificial intelligence software for healthcare; artificial intelligence software, in particular for use in the pharmaceutical industry or biotech industry. | ACTIVE | — |
| 035 | Marketing; publicity and sales promotion services; development of marketing strategies and concepts; public relations services; publicity; marketing services; business consultancy in the field of optimisation of documentation processes; consultancy relating to business processes for regulatory compliance in the field of good manufacturing practice (GMP); consultancy relating to the implementation of quality assurance processes in companies; assistance in the automation of processes in the pharmaceutical sectors, in particular in the field of manufacturing pharmaceutical agents and medicines, in particular relating to the automation of processes in connection with electronic batch records (EBR), a batch record review (BRR), master batch records (MBR) or a track and trace process; business consultancy in the field of process automation in the pharmaceutical industry; assistance in quality and compliance processes through automated communication and data analysis in the pharmaceutical sector, in particular in the field of manufacturing pharmaceutical agents and medicines; assistance in qualification and/or validation processes in the pharmaceutical sector, in particular in the field of manufacturing pharmaceutical agents and medicines. | ACTIVE | — |
| 042 | Development, providing and maintenance of software featuring chatbot integration for assistance in the creation, processing, adaptation, maintenance, providing, development and/or verification management of electronic batch records (EBR), a batch record review (BRR), master batch records (MBR) or a track and trace process, in particular manufacturing execution software (MES); optimisation of software for the development, providing and maintenance of software featuring chatbot integration for assistance in the creation, processing, adaptation, maintenance, providing, development and/or verification management of electronic batch records (EBR), a batch record review (BRR), master batch records (MBR) or a track and trace process, in particular manufacturing execution software (MES); software creation; software customisation services; software development; custom design of software packages; technological consultancy in connection with the development and implementation of digital solutions for GMP-compliant documentation processes; development and implementation of software solutions for electronic documentation according to GMP standards; providing of software as service (SaaS) for GMP-compliant documentation. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 15, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 14, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 7, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 6, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 6, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 5, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |